BRTX Stock Summary and Trading Ideas (Biorestorative Therapies | NASDAQ:BRTX)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Biorestorative Therapies trades on the NASDAQ stock market under the symbol BRTX.

As of August 25, 2026, BRTX stock price climbed to $0.22 with 100,201 million shares trading.

BRTX has a beta of 1.87, meaning it tends to be more sensitive to market movements. BRTX has a correlation of 0.02 to the broad based SPY ETF.

BRTX has a market cap of $5.67 million. This is considered a Sub-Micro Cap stock.

Last quarter Biorestorative Therapies reported $23,170 in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-236,830 and exceeded earnings estimates by $.18.

In the last 3 years, BRTX traded as high as $3.67 and as low as $.16.

The top ETF exchange traded funds that BRTX belongs to (by Net Assets): VXF.

BRTX has underperformed the market in the last year with a return of -85.5%, while SPY returned +19.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BRTX shares. However, BRTX has outperformed the market in the last 3 month and 2 week periods, returning +7.0% and +10.7%, while SPY returned +3.0% and -0.9%, respectively. This indicates BRTX has been having a stronger performance recently.

BRTX support price is $.20 and resistance is $.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BRTX shares will trade within this expected range on the day.